BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vos B, Rozema T, Miller RC, Hendlisz A, Van Laethem JL, Khanfir K, Weber DC, El Nakadi I, Van Houtte P. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study: Small-cell carcinoma of the esophagus. Diseases of the Esophagus 2011;24:258-64. [DOI: 10.1111/j.1442-2050.2010.01133.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Guo L, Zou X, Gu Y, Yi L, Zhao J, Wu G. Apatinib Combined with Irinotecan in the Treatment of Advanced Small-Cell Esophageal Carcinoma: A Case Report. Onco Targets Ther 2021;14:1989-95. [PMID: 33776448 DOI: 10.2147/OTT.S295067] [Reference Citation Analysis]
2 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou FY, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.Dis Esophagus. 2017;30:1-7. [PMID: 28575250 DOI: 10.1093/dote/dox041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Goh N, Yeo DXW, Amitbhai SK, Aung MO, Ho YH, Koura AN, Rao J. A rare case of bipartite combined tumour of the oesophagus. World J Surg Oncol 2019;17:79. [PMID: 31060613 DOI: 10.1186/s12957-019-1623-7] [Reference Citation Analysis]
4 Gan J, Zhang Y, Ke X, Tan C, Ren H, Dong H, Jiang J, Chen S, Zhuang Y, Zhang H. Dysregulation of PAK1 Is Associated with DNA Damage and Is of Prognostic Importance in Primary Esophageal Small Cell Carcinoma. Int J Mol Sci 2015;16:12035-50. [PMID: 26023713 DOI: 10.3390/ijms160612035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
5 Feng JF, Zhao HG, Liu JS, Chen QX. Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus. Onco Targets Ther 2013;6:1147-51. [PMID: 24009425 DOI: 10.2147/OTT.S50039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
6 Ye L, Lu H, Wu L, Zhang L, Shi H, Wu HM, Tu P, Li M, Wang FY. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases. BMC Cancer. 2019;19:1234. [PMID: 31852479 DOI: 10.1186/s12885-019-6420-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xu L, Li Y, Liu X, Sun H, Zhang R, Zhang J, Zheng Y, Wang Z, Liu S, Chen X. Treatment Strategies and Prognostic Factors of Limited-Stage Primary Small Cell Carcinoma of the Esophagus. J Thorac Oncol. 2017;12:1834-1844. [PMID: 29024756 DOI: 10.1016/j.jtho.2017.09.1966] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
8 Meng M, Zaorsky NG, Jiang C, Tian L, Wang H, Liu C, Wang J, Tao Z, Sun Y, Wang J, Pang Q, Zhao L, Yuan Z, Ping W. Radiotherapy and chemotherapy are associated with improved outcomes over surgery and chemotherapy in the management of limited-stage small cell esophageal carcinoma. Radiotherapy and Oncology 2013;106:317-22. [DOI: 10.1016/j.radonc.2013.01.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
9 Tao H, Li F, Wang J, Dong W, Gao J, Jiao S, Hu Y. Management of treatment-naïve limited-stage small cell esophagus carcinoma. Saudi Med J 2015;36:297-303. [PMID: 25737171 DOI: 10.15537/smj.2015.3.11368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
10 Ku JW, Zhang DY, Song X, Li XM, Zhao XK, Lv S, Hu SJ, Cheng R, Zhou F, Wu HF, Wang LD. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dox041] [Reference Citation Analysis]
11 Wong AT, Shao M, Rineer J, Osborn V, Schwartz D, Schreiber D. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base. Dis Esophagus. 2017;30:1-5. [PMID: 27860114 DOI: 10.1111/dote.12487] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
12 Chen WW, Wang F, Chen S, Wang L, Ren C, Luo HY, Wang FH, Li YH, Zhang DS, Xu RH. Detailed analysis of prognostic factors in primary esophageal small cell carcinoma. Ann Thorac Surg. 2014;97:1975-1981. [PMID: 24726599 DOI: 10.1016/j.athoracsur.2014.02.037] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
13 Gao R, Zhang Y, Wen XP, Fu J, Zhang GJ. Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series. Dis Esophagus 2014;27:764-9. [PMID: 24118373 DOI: 10.1111/dote.12149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao K, Huang Z, Si Y, Sun L, Yu J, Meng X. Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus. Cancer Manag Res 2021;13:613-23. [PMID: 33531834 DOI: 10.2147/CMAR.S278914] [Reference Citation Analysis]
15 Jacob J, Chargari C, Helissey C, Ferrand FR, Ceccaldi B, Le Moulec S, Bauduceau O, Fayolle M, Védrine L. [Neuroendocrine carcinoma of the digestive tract: a literature review]. Rev Med Interne 2013;34:700-5. [PMID: 23871177 DOI: 10.1016/j.revmed.2013.02.013] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Xiao Q, Xiao H, Ouyang S, Tang J, Zhang B, Wang H. Primary small cell carcinoma of the esophagus: Comparison between a Chinese cohort and Surveillance, Epidemiology, and End Results (SEER) data. Cancer Med. 2019;8:1074-1085. [PMID: 30740907 DOI: 10.1002/cam4.2001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
17 Zhou Q, Zou BW, Xu Y, Xue JX, Meng MB, Liu FJ, Deng L, Ma DY, Ao R, Lu Y. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus. Tumour Biol 2015;36:1539-48. [PMID: 25374063 DOI: 10.1007/s13277-014-2718-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
18 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Reference Citation Analysis]
19 Akazawa N, Kawachi H, Kitagaki K, Seki T, Kawaragi S, Yuzawa M, Sekine M, Kobayashi M, Nakajima Y, Kawano T, Eishi Y. Neuroendocrine carcinoma of the esophagus: clinicopathologic study of 10 cases and verification of the diagnostic utility of mASH1, NeuroD1, and PGP9.5. Esophagus 2014;11:245-57. [DOI: 10.1007/s10388-014-0444-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Queen T, Altamimi BA, Chang C, Glass J. Small Cells, Big Problems. Dig Dis Sci 2016;61:384-8. [PMID: 26581216 DOI: 10.1007/s10620-015-3962-8] [Reference Citation Analysis]
21 Zhang Y, Li C, Chen M. Prognostic value of immunohistochemical factors in esophageal small cell carcinoma (ESCC): analysis of clinicopathologic features of 73 patients. J Thorac Dis 2018;10:4023-31. [PMID: 30174845 DOI: 10.21037/jtd.2018.06.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Zhu Y, Qiu B, Liu H, Li Q, Xiao W, Hu Y, Liu M. Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution. Dis Esophagus 2014;27:152-8. [PMID: 23639106 DOI: 10.1111/dote.12069] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
23 Morita M, Taguchi K, Kagawa M, Nakanoko T, Uehara H, Sugiyama M, Ota M, Ikebe M, Sugimachi K, Esaki T, Toh Y. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract. Int J Clin Oncol. 2020;25:842-850. [PMID: 32036480 DOI: 10.1007/s10147-020-01631-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) 2015;5:119-76. [PMID: 26854147 DOI: 10.3390/diagnostics5020119] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
25 Hosseini S, Salek R, Nasrolahi H, Mohammadianpanah M, Judi M. Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases. Iran Red Crescent Med J 2015;17:e20353. [PMID: 26734479 DOI: 10.5812/ircmj.20353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A; NIKE. A rare rarity: Neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol 2019;137:92-107. [PMID: 31014519 DOI: 10.1016/j.critrevonc.2019.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
27 Situ D, Lin Y, Long H, Zhang L, Lin P, Zheng Y, Jiang L, Tan Z, Meng Y, Ma G. Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus. The Annals of Thoracic Surgery 2013;95:1057-62. [DOI: 10.1016/j.athoracsur.2012.11.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
28 Qie S, Wang XF, Ran YG, Liu ML, Cui GM, Shi HY. Nomogram for predicting the survival of patients with small cell carcinoma of the esophagus: A population study based on the surveillance, epidemiology, and end results database. Medicine (Baltimore) 2021;100:e25427. [PMID: 33847642 DOI: 10.1097/MD.0000000000025427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Hou X, Wei JC, Wu JX, Wang X, Fu JH, Lin P, Yang HX. Multidisciplinary modalities achieve encouraging long-term survival in resectable limited-disease esophageal small cell carcinoma. PLoS One 2013;8:e69259. [PMID: 23874925 DOI: 10.1371/journal.pone.0069259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
30 Xie MR, Xu SB, Sun XH, Ke L, Mei XY, Liu CQ, Ma DC. Role of surgery in the management and prognosis of limited-stage small cell carcinoma of the esophagus. Dis Esophagus. 2015;28:476-482. [PMID: 24787553 DOI: 10.1111/dote.12230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
31 Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther. 2015;8:437-444. [PMID: 25709477 DOI: 10.2147/ott.s76048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
32 Sepulvida MBC, Amaral AV, de Campos PTR, Teixeira CO, Teixeira MAB. Small-cell neuroendocrine carcinoma of the esophagus: an autopsy case report. Autops Case Rep 2014;4:15-9. [PMID: 28652988 DOI: 10.4322/acr.2014.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Katada C, Komori S, Yoshida T, Kawakami S, Watanabe A, Ishido K, Azuma M, Wada T, Hosoda K, Yamashita K, Hiki N, Tanabe S, Ishiyama H, Koizumi W. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus. Esophagus 2020;17:135-40. [PMID: 31321580 DOI: 10.1007/s10388-019-00686-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Song Y, Wang W, Tao G, Zhu W, Zhou X, Pan P. Survival benefit of radiotherapy to patients with small cell esophagus carcinoma: an analysis of Surveillance Epidemiology and End Results (SEER) data. Oncotarget 2016;7:15474-80. [PMID: 26943276 DOI: 10.18632/oncotarget.6764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Tustumi F, Takeda FR, Uema RH, Pereira GL, Sallum RA, Cecconello I. Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature. Arq Gastroenterol. 2017;54:4-10. [PMID: 28079231 DOI: 10.1590/s0004-2803.2017v54n1-01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
36 Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, Sun Q, Yang J, Huang L, Ye Q. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37:467-483. [PMID: 23426118 DOI: 10.1097/PAS.0b013e31826d2639] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
37 Peng C, Shen S, Zhang X, Zou X. Limited stage small cell carcinoma of the gastrointestinal tract: a clinicopathologic and prognostic analysis of 27 cases. Rare Tumors 2013;5:e6. [PMID: 23772305 DOI: 10.4081/rt.2013.e6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
38 Xu X, Yang Y, Cao L, Li F, Zhao J, Guo B, Cui X, He M. Lymph Node Metastasis and Recurrence in Primary Small Cell Carcinoma of the Esophagus: A Retrospective Study of 125 Cases. Cancer Biother Radiopharm 2019;34:459-63. [PMID: 31120315 DOI: 10.1089/cbr.2019.2800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
39 Deng HY, Ni PZ, Wang YC, Wang WP, Chen LQ. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection. J Thorac Dis. 2016;8:1250-1256. [PMID: 27293844 DOI: 10.21037/jtd.2016.04.21] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
40 Wang SY, Mao WM, Du XH, Xu YP, Zhang SZ. The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system. Chin J Cancer. 2013;32:342-352. [PMID: 23114087 DOI: 10.5732/cjc.012.10161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
41 Chin JL, O'Toole D. Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors. Clin Endosc. 2017;50:520-529. [PMID: 29207862 DOI: 10.5946/ce.2017.181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]